logo
09:29 Jun 18

Brooks Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
67.98
+1.01 (+1.51%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Brooks Laboratories Ltd. Financials

Brooks Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
67.98
+1.01 (+1.51%)
09:29 Jun 18
Quality
image/svg+xml

71/100
High Financial Strength

Valuation
image/svg+xml

57/100
Affordable Valuation

Technical

47/100
Technically Neutral

Strength

14

Weakness

3

Opportunity

1

Threats

0

20.04 %

ROE %

16.59 %

ROA %

8.35

EPS

41.64

BVPS

28.67 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
91.08 63.2 79.49 82.56 85.74
Operating Expenses +
105.43 89.62 76.28 77.62 78.67
Raw Material
64.89 46.42 55.22 54.22 51.86
Increase Decrease in Cost
-2.1 4.18 1.4 -0.15 -0.84
Other Manufacturing Expense
9.51 7.13 4.44 0 0
Employee Cost
19.15 17.34 10.54 12.96 15.16
Miscellaneous Expenses
17.9 24.29 25.68 24.95 16.99
Operating Profit
-14.35 -26.42 3.21 4.94 7.07
Other Income
0.91 0.2 0.96 0.88 1.17
Depreciation
7.35 7.03 1.77 1.6 1.59
Interest
3.1 2.18 0.84 1.03 0.84
Profit before tax and exceptio..
-23.9 -35.42 1.55 3.19 5.8
Exceptional Items
0 0.36 0 0 0
PBT
-23.9 -35.07 1.55 3.19 5.8
Provision for Taxation
-4.59 -7.32 0.03 0.18 0
Net Profit
-19.31 -27.74 1.53 3.02 5.8
NET Profit after MI
-16.19 -20.9 -19.59 -9.97 24.58
EPS
-7.82 -12.57 -7.65 -3.72 8.35
Operating Profit Margin (%)
-15.76 -41.8 4.04 5.98 8.25
Net Profit Margin (%)
-17.78 -33.07 -24.64 -12.08 28.67

Brooks Laboratories Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: